As per reports, it has been revealed that Lookout, a mobile security company has been entering into a deal with France Telecom, which is the owner of mobile carrier Orange. It has been found that France Telecom has decided to invest in the plans of Lookout, which now aims to become a household name.
It seems that a number of deals have taken place between both the companies. It has been found that both have also signed a deal in which Lookout will be preloaded in all the gadgets that will be sold by Orange.
It is said that the deal will prove fruitful, as Lookout will be available in the gadgets. If not less, then also Orange has 169 million subscribers, so one can expect that worth of the deal. The deal is said to get active in early 2013.
For now, the worth of deal has not been known, but it is said that it could be not less than 20 million. Experts said that they have quoted the amount by seeing the capabilities and position of both the companies.
"We are including Lookout into our service bundles, but we also see mobile security as an important part of the bigger security-privacy-personal data issue", said Xavier Perret from Orange.
In a recent announcement, Sega has revealed that its Steam catalog of classic Genesis and Mega Drive games is being updated with a new 3D interface --- the Sega Mega Drive Classics Hub.
Announcing the Classics Hub, Sega said that the new...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
Electric vehicle manufacturer Tesla has said in a recent announcement that it is now offering free trials of its autopilot software on Model S and Model X cars. The free trials give the owners of Model S and Model X cars a chance to test...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has revealed in a recent announcement that its latest Nik Collection of photo...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Wednesday, European competition authorities unveiled...
The button white mushroom edited using CRISPR has...
In a Tuesday announcement, Supergiant Games studio’s...
According to a CNN report, the Federal Investigation...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).